ESRX
Income statement / Annual
Last year (2017), Express Scripts Holding Company's total revenue was $100.06 B,
a decrease of 0.22% from the previous year.
In 2017, Express Scripts Holding Company's net income was $4.52 B.
See Express Scripts Holding Company,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
| Period Ended |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
12/31/2010 |
12/31/2009 |
12/31/2008 |
| Operating Revenue |
$100.06 B |
$100.29 B |
$101.75 B |
$100.89 B |
$104.10 B |
$93.86 B |
$46.13 B |
$44.97 B |
$24.75 B |
$21.98 B |
| Cost of Revenue |
$91.30 B
|
$91.67 B
|
$93.35 B
|
$92.96 B
|
$95.97 B
|
$86.53 B
|
$42.92 B
|
$42.02 B
|
$22.32 B
|
$19.94 B
|
| Gross Profit |
$8.76 B
|
$8.62 B
|
$8.40 B
|
$7.93 B
|
$8.13 B
|
$7.33 B
|
$3.21 B
|
$2.96 B
|
$2.43 B
|
$2.04 B
|
| Gross Profit Ratio |
0.09
|
0.09
|
0.08
|
0.08
|
0.08
|
0.08
|
0.07
|
0.07
|
0.1
|
0.09
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.27 B
|
$3.53 B
|
$4.06 B
|
$4.32 B
|
$4.58 B
|
$4.55 B
|
$898.20 M
|
$887.30 M
|
$932.00 M
|
$760.40 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.27 B
|
$3.53 B
|
$4.06 B
|
$4.32 B
|
$4.58 B
|
$4.55 B
|
$898.20 M
|
$887.30 M
|
$932.00 M
|
$760.40 M
|
| Cost And Expenses |
$94.57 B
|
$95.20 B
|
$97.41 B
|
$97.28 B
|
$100.55 B
|
$91.07 B
|
$43.82 B
|
$42.90 B
|
$23.25 B
|
$20.70 B
|
| Interest Income |
$42.90 M
|
$34.10 M
|
$24.80 M
|
$28.00 M
|
$41.90 M
|
$10.60 M
|
$12.40 M
|
$4.90 M
|
$5.30 M
|
$13.00 M
|
| Interest Expense |
$607.90 M
|
$694.80 M
|
$500.30 M
|
$582.90 M
|
$596.10 M
|
$619.00 M
|
$299.70 M
|
$167.10 M
|
$194.40 M
|
$77.60 M
|
| Depreciation & Amortization |
$1.84 B
|
$2.19 B
|
$2.38 B
|
$2.29 B
|
$2.52 B
|
$1.87 B
|
$253.40 M
|
$244.70 M
|
$109.90 M
|
$97.70 M
|
| EBITDA |
$7.34 B |
$7.28 B |
$6.72 B |
$5.89 B |
$6.07 B |
$4.68 B |
$2.58 B |
$2.32 B |
$1.61 B |
$1.39 B |
| EBITDA Ratio |
0.07
|
0.07
|
0.07
|
0.06
|
0.06
|
0.05
|
0.06
|
0.05
|
0.07
|
0.06
|
| Operating Income Ratio |
0.05
|
0.05
|
0.04
|
0.04
|
0.03
|
0.03
|
0.05
|
0.05
|
0.06
|
0.06
|
| Total Other Income/Expenses Net |
-$565.00 M
|
-$660.70 M
|
-$475.50 M
|
-$536.20 M
|
-$521.40 M
|
-$593.50 M
|
-$287.30 M
|
-$162.20 M
|
-$189.10 M
|
-$66.90 M
|
| Income Before Tax |
$4.93 B
|
$4.43 B
|
$3.86 B
|
$3.07 B
|
$3.03 B
|
$2.19 B
|
$2.02 B
|
$1.91 B
|
$1.31 B
|
$1.21 B
|
| Income Before Tax Ratio |
0.05
|
0.04
|
0.04
|
0.03
|
0.03
|
0.02
|
0.04
|
0.04
|
0.05
|
0.06
|
| Income Tax Expense |
$397.30 M
|
$999.50 M
|
$1.36 B
|
$1.03 B
|
$1.10 B
|
$833.30 M
|
$748.60 M
|
$704.10 M
|
$482.80 M
|
$434.00 M
|
| Net Income |
$4.52 B
|
$3.40 B
|
$2.48 B
|
$2.01 B
|
$1.84 B
|
$1.31 B
|
$1.28 B
|
$1.18 B
|
$827.60 M
|
$776.10 M
|
| Net Income Ratio |
0.05
|
0.03
|
0.02
|
0.02
|
0.02
|
0.01
|
0.03
|
0.03
|
0.03
|
0.04
|
| EPS |
7.79 |
5.43 |
3.59 |
2.68 |
2.28 |
1.8 |
2.55 |
2.19 |
1.57 |
1.56 |
| EPS Diluted |
7.74 |
5.39 |
3.56 |
2.64 |
2.25 |
1.76 |
2.53 |
2.17 |
1.56 |
1.54 |
| Weighted Average Shares Out |
$580.10 M
|
$626.90 M
|
$689.00 M
|
$750.30 M
|
$808.60 M
|
$731.30 M
|
$500.90 M
|
$538.50 M
|
$527.00 M
|
$497.80 M
|
| Weighted Average Shares Out Diluted |
$583.40 M
|
$631.40 M
|
$695.30 M
|
$759.10 M
|
$821.60 M
|
$747.30 M
|
$505.00 M
|
$544.00 M
|
$532.20 M
|
$503.60 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
